Search

everythinglearnresearchcommunity

for

Search:↓

Inhibiting testosterone 5alpha-reductase may help treat benign prostatic hyperplasia.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Male hormones may make COVID-19 worse, while substances that block these hormones could lessen symptoms.

Dutasteride and finasteride affect different cell types differently.

Norplant implants lower some androgen levels but don't significantly change sexual function.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Effective treatments for excessive body hair in women include drugs that block androgens, sometimes combined with oral contraceptives.

The document aims to compare the effectiveness of different single treatments for male pattern hair loss.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

Minoxidil can reduce functions related to androgen receptors.

Dutasteride is more effective for male pattern baldness than finasteride, and black cohosh extract BNO 1055 is as effective as conjugated estrogens in treating postmenopausal symptoms, with added benefits in reducing sweating and mental symptoms.

Topical finasteride may help treat facial hirsutism in women.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Liposomes can make the antiandrogen RU 58841 more effective for skin application by reducing absorption, increasing skin retention, and targeting sebaceous structures.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Hormonal contraceptives and related compounds can increase health risks like thrombosis and affect sexual function.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Glycyrrhiza glabra extract may prevent hair loss like finasteride.

Oral contraceptives and antiandrogens are the best treatments for hirsutism.